[Human T-cell lymphotrophic virus type I and T-cell lymphoma] NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Human T-cell lymphotrophic virus type I and T-cell lymphoma]

Tidsskr Nor Laegeforen. 1996 Jan 20;116(2):238-41. Unique Identifier : AIDSLINE MED/96229836
Loraas A; Lote K; Samdal HH; Beiske K; Langholm R; Onkologisk avdeling Det Norske Radiumhospital, Oslo.

Abstract: Human T-cell lymphotropic virus type I is an oncogenic retrovirus, endemic in Southwestern Japan, the Caribbean, some parts of Africa and Central and South America. The virus is etiologically associated with adult T-cell leukemia/lymphoma and a myelopathy called tropical spastic paraparesis or HTLV-I associated myelopathy. Transmission of the virus is almost identical to that of HIV. The latency period before onset of clinical symptoms can last from a few years (tropical spastic paraparesis) up to several decades (adult T-cell leukemia/lymphoma). Four different clinicopathological subtypes of the T-cell neoplasia are known, and in this article we describe two patients with the subtype lymphoma.
Keywords: Adult Bone Marrow/PATHOLOGY Case Report English Abstract Human HTLV-I Antibodies/ANALYSIS HTLV-II Antibodies/ANALYSIS Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/DIAGNOSIS/ PATHOLOGY/TRANSMISSION/*VIROLOGY Lymph Nodes/PATHOLOGY Male Serodiagnosis JOURNAL ARTICLEKWDadultbonemarrow/pathologycasereportenglishabstracthumanhtlv-iantibodies/analysishtlv-iiantibodies/analysisleukemia-lymphoma,t-cell,acute,htlv-i-associated/diagnosis/pathology/transmission/KWDvirologylymphnodes/pathologymaleserodiagnosisjournalarticle
960930
M9690871

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .